|
Aug 8
|
Faron Pharmaceuticals Ltd: Holding(s) in Company
|
|
Aug 8
|
Faron Announces Extension to its Key Patent Family around Bexmarilimab and Targeting Clever-1 in Cancers with a New US Patent Granted
|
|
Aug 7
|
Faron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rights in connection with Advanced Amortisation of the First Tranche Bonds
|
|
Aug 6
|
UK Growth Companies With High Insider Ownership For August 2025
|
|
Aug 6
|
Inside Information: Faron to Present Updated BEXMAB Data in Frontline HR-MDS to FDA; Complete Remission Rate Substantially Increased to 43%
|
|
Aug 4
|
UK Growth Companies With High Insider Ownership In August 2025
|
|
Jul 30
|
Faron Announces Acceptance of Bexmarilimab Data for Oral Presentation at ESMO 2025
|
|
Jul 30
|
Top UK Growth Companies With High Insider Ownership In July 2025
|
|
Jul 29
|
UK Growth Stocks With Insider Ownership And Up To 91% Earnings Growth
|
|
Jul 25
|
Exploring High Growth Tech Stocks in the United Kingdom July 2025
|
|
Jul 24
|
UK Growth Companies With High Insider Ownership Expecting 29% Earnings Growth
|
|
Jul 18
|
UK Growth Companies With High Insider Ownership July 2025
|
|
Jul 17
|
3 UK Growth Companies With High Insider Ownership Expecting Up To 67% Earnings Growth
|
|
Jul 1
|
3 UK Growth Companies With Up To 25% Insider Ownership
|
|
Jun 30
|
Faron Pharmaceuticals Ltd: Director/PCA Dealing
|
|
Jun 30
|
UK Growth Companies With Strong Insider Confidence In June 2025
|
|
Jun 30
|
Faron-Supported Research in Theranostics Identifies Secreted Clever-1 (sClever-1) as an Independent Driver of Immune Evasion in Cancer, Deepening the Understanding of Bexmarilimab’s Mode of Action
|
|
Jun 26
|
Exploring High Growth Tech Stocks in the UK for June 2025
|
|
Jun 25
|
UK Insider-Owned Growth Stocks For June 2025
|
|
Apr 24
|
Faron Announces Acceptance of Bexmarilimab Phase II Data for Oral Presentation at ASCO 2025
|